Form D · Biotechnology
EKSO BIONICS HOLDINGS, INC.
Richmond, CA · CIK 0001549084
Offering snapshot reported Feb 12, 2021 · SEC filing
- Reported sold
- $0 Offering amount: $3.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2021 | Initial | $0 | No comparison | 4 | SEC filing |
| Jun 25, 2020 | Initial | $0 | No comparison | 7 | SEC filing |
| Dec 4, 2014 | Initial | $22,755,500 | No comparison | 157 | SEC filing |
| Jan 30, 2014 | Initial | $50,794,281 | No comparison | 110 | SEC filing |
| Jan 30, 2014 | Initial | $27,436,500 | No comparison | 200 | SEC filing |
| Jan 30, 2014 | Initial | $2,300,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389424
Source: Form D, filed Feb 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russ Angold | Executive |
| Daniel Boren | Director |
| John F. Glenn | Executive |
| Marilyn Hamilton | Director |
| Nathan Harding | Director, Executive |
| Jason Jones | Executive |
| Charles Li | Director |
| Thomas Looby | Executive |
| Frank Moreman | Executive |
| Jack Peurach | Director, Executive |
| Max Scheder Bieschin | Executive |
| Thomas Schreck | Director |
| William Shaw | Executive |
| Steven Sherman | Director, Executive |
| Stanley Stern | Director |
| Ted Wang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1414 Harbour Way South Suite 1201
Richmond, CA, 94804
Richmond, CA, 94804